SOUFFLÉ THERAPEUTICS — 2282346
Application number
2282346
International Registration Number
1751824
Type(s)
Standard Characters
Category
Trademark
CIPO Status
APPROVED
TM5 status
LIVE/APPLICATION/
Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
Filed
2023-08-16
International Registration
2023-08-16
Registration Expiry Date
2033-08-16
Applicant
Soufflé Therapeutics, Inc.
250 Arsenal Street, Suite 220
Watertown MA 02472
UNITED STATES OF AMERICA
Agent
OSLER, HOSKIN & HARCOURT LLP
Suite 320, World Exchange Plaza
100 Queen Street
Ottawa,
ONTARIO K1P1J9
Documents
Index headings
- SOUFFLÉ THERAPEUTICS
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical antibodies for use as anti-infectives; anti-inflammatories; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations for the treatment of bacterial skin infections, dermatitis, skin pigmentation diseases and psoriasis; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin and nail diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and malignant tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; vaccines for human use.
Services (Nice class & Statement)
- 42
- (1) Pharmaceutical research and development; consulting services in the field of pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; providing information in the field of pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals and clinical trials.
Claims
- Priority Filing Date: February 17, 2023, Country or Office: UNITED STATES OF AMERICA, Application No. 97799177 in association with the same kind of goods and in association with the same kind of services
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Name and Address / Nom et adresse DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2025-04-16 DATE OF CHANGE / DATE DE CHANGEMENT: 2025-03-11 COMMENTS / COMMENTAIRES: From: Soufflé Therapeutics, Inc. To: Soufflé Therapeutics, Inc.Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2023-08-16 | Registration | |
| International Registration | 2023-08-16 | 2033-08-16 | |
| Created | 2023-09-20 | ||
| Formalized | 2023-09-20 | ||
| Designation Notification - Madrid Protocol | 2023-09-21 | 2025-03-21 | |
| Notification of Possible Opposition Sent | 2024-07-22 | ||
| Search Recorded | 2024-12-27 | ||
| Examiner's First Report | 2024-12-27 | 2025-06-27 | |
| Total Provisional Refusal | 2024-12-27 | 2025-06-27 | |
| Amendment to Application | 2025-04-17 | DP:2025-04-16 Effective Date: 2025-03-11 | |
| Agent Changed | 2025-06-13 | From/De: To/A: 69 | |
| Extension of Time | 2025-07-03 | 2025-12-27 | Request Letter Date: 2025/06/26 |
| Approved | 2026-04-22 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2026-04-22 | APPROVED BY PROGRAM EX200M1 |